SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,888,278 | +7.1% | 164,451 | -2.8% | 0.02% | +13.6% |
| Q2 2023 | $32,572,124 | -49.7% | 169,241 | -47.0% | 0.02% | -52.2% |
| Q1 2023 | $64,709,008 | +41.4% | 319,598 | -10.3% | 0.05% | +35.3% |
| Q4 2022 | $45,762,926 | +14.3% | 356,104 | +21.7% | 0.03% | +6.2% |
| Q3 2022 | $40,043,000 | -14.5% | 292,650 | +10.5% | 0.03% | -8.6% |
| Q2 2022 | $46,858,000 | +85.2% | 264,824 | +50.8% | 0.04% | +118.8% |
| Q1 2022 | $25,295,000 | +1.2% | 175,592 | +8.6% | 0.02% | +6.7% |
| Q4 2021 | $25,007,000 | -10.5% | 161,753 | -1.8% | 0.02% | -16.7% |
| Q3 2021 | $27,956,000 | +6.0% | 164,637 | -1.4% | 0.02% | +5.9% |
| Q2 2021 | $26,373,000 | +49.3% | 167,046 | +31.3% | 0.02% | +41.7% |
| Q1 2021 | $17,669,000 | -16.6% | 127,245 | +5.2% | 0.01% | -25.0% |
| Q4 2020 | $21,180,000 | – | 120,930 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |